Article Figures & Data
Figures
- Figure 1
- Left ventricular ejection fraction by treatment modality and viability.
Tables
Characteristic All patients (n=106) Viable (n=68) Non-viable (n=38) P-value Age (years), median (IQR) 66 (59-73) 66 (58-74) 68 (60-73) 0.586 Gender - Male 95 (89.6) 61 (89.7) 34 (89.5) 0.896 BMI (kg/m2), median (IQR) 28.3 (25-32) 28.6 (24.8-32.1) 28.1 (25.3-30.8) 0.661 Nationality - Saudi 105 (99.1) 68 (100) 37 (97.4) 0.179 Comorbidities DM 91 (85.8) 57 (83.8) 34 (89.5) 0.423 HTN 82 (77.4) 53 (77.9) 29 (76.3) 0.848 DLP 66 (62.3) 38 (55.9) 28 (73.7) 0.069 Smoking 29 (27.4) 20 (29.4) 9 (23.7) 0.526 Cardiac pathology MI 42 (39.6) 21 (30.9) 21 (55.3) 0.013* CABG 10 (9.4) 6 (8.8) 4 (10.5) 0.743 PCI 14 (13.2) 7 (10.3) 7 (18.4) 0.238 Medications ARB or ACEI 89 (84.0) 58 (85.3) 31 (81.6) 0.617 BB 93 (87.7) 61 (89.7) 32 (84.2) 0.408 Nitrates 45 (42.5) 30 (44.1) 15 (39.5) 0.643 Loop diuretics 80 (75.5) 51 (75.0) 29 (76.3) 0.877 MRA 60 (56.6) 41 (60.3) 19 (50.0) 0.305 Values as presented as number and percentages (%). IQR: interquartile range, BMI: body mass index, DM: diabetes mellitus, HTN: hypertension, DLP: dyslipidemia, MI: myocardial Infarction, CABG: coronary artery bypass graft, PCI: Percutaneous coronary interventionm ARB: angiotensin receptor blockers, ACEI: angiotensin converting enzyme inhibitors, BB: beta blockers, MRA: mineralocorticoid receptor antagonists. *Significant p-value.
- Table 2
- Imaging modalities, treatment and cardiac outcomes based on the myocardial viability status.
Characteristic All patients (n=106) Viable (n=68) Non-viable (n=38) P-value Modality ECHO 10 (9.4) 6 (8.8) 4 (10.5) MRI 95 (89.6) 61 (89.7) 34 (89.5) 0.728 Nuclear 1 (0.9) 1 (1.5) 0 (0) Treatment CABG 24 (22.6) 22 (32.4) 2 (5.3) Medical 64 (60.4) 32 (47.1) 32 (84.2) <0.001* PCI 18 (17) 14 (20.6) 4 (10.5) Admissions for cardiac cause, median (IQR) 0.5 (0-1) 0 (0-1) 1 (0-2) 0. 051 Dilated heart 65 (61.3) 42 (61.8) 23 (60.5) 0.898 Status 0.153 Alive 81 (76.4) 56 (82.4) 25 (65.8) Died due to cardiac cause 13 (12.3) 6 (8.8) 7 (18.4) Died due to non-cardiac cause 12 (11.3) 6 (8.8) 6 (15.8) LVEF LVEF at baseline, median (IQR) 30 (25-36) 30 (25-37) 31 (25-35) 0. 817 LVEF post treatment, median (IQR) 33 (27-40) 35 (30-42) 30 (25-35) 0. 016* LVEDI, median (IQR) 75 (59-89) 76 (59-89) 71 (62-95) 0. 957 Creatinine clearance, median (IQR) 68 (56-82) 70 (54-81) 67 (59-82) 0. 935 Values are presented as number s and percentages (%). IQR: interquartile range, ECHO: echocardiography, MRI: magnetic resonance imaging, CABG: coronary artery bypass graft, PCI: Percutaneous coronary intervention, LVEF: left ventricular ejection fraction, LVED: left ventricular end diastolic index, *Significant p-value.
- Table 3
- Characteristics and outcome of patients who received medical therapy alone based on viability status.
Characteristic All patients (n=106) Viable (n=68) Non-viable (n=38) P-value Gender - Male 57 (89.1) 29 (90.6) 28 (87.5) 0.971 Admissions for cardiac cause, median (IQR) 1 (0-1) 0.5 (0-1) 1 (0-1.3) 0.532 Status 0.141 Alive 46 (71.9) 26 (81.2) 20 (62.5) Died due to cardiac cause 9 (14.1) 2 (6.2) 7 (21.9) Died due to non-cardiac cause 9 (14.1) 4 (12.5) 5 (15.6) LVEF LVEF at Baseline, median (IQR) 30 (25-35) 30 (25.4-34.2) 31 (24.8-35) 0. 930 LVEF Post treatment, median (IQR) 32 (25-37.3) 34 (30.3-38.1) 30 (25-35.8) 0. 094 Values are presented as number s and percentages (%). LVEF= Left ventricular ejection fraction.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.